Last updated: March 1, 2026
What Does Patent MX2017001332 Cover?
Patent MX2017001332, filed in Mexico, protects a pharmaceutical invention related to a specific drug formulation or method. Although details vary, the scope typically centers on its unique composition, method of production, or use. Accessing the official patent document reveals the claims delineate the boundaries of protection.
Claims Summary:
- The patent generally includes a set of claims defining the invention's core features.
- Primary claim(s) specify the active agent(s) and their configuration or concentration.
- Dependent claims expand on the primary one, addressing alternative compositions, methods of synthesis, or specific application methods.
In detailed terms:
- The claims likely specify the chemical structure of the active ingredient(s).
- It defines the formulation components, such as excipients, stabilizers, or carriers.
- The claims may cover a method of manufacturing the drug or its administration regimen.
Key attributes of the claims:
| Element |
Description |
| Scope of protection |
Most claims focus on a formulation comprising specific active substances and excipients, with claims extending to methods of production or use. |
| Breadth of claims |
Depending on the language, claims range from broad (covering any formulation with the specified active) to narrow (specific concentration ranges or manufacturing steps). |
| Limitations |
Some claims specify the dosage, administration route, or stability features to reinforce novelty or inventive step. |
How Does the Patent Landscape Look in Mexico?
The Mexican pharmaceutical patent landscape includes over 17,000 active patents, with a rising trend in chemical and pharmaceutical patents over the last decade, accounting for approximately 20% of all patents granted annually [1].
Major patent classes relevant here:
- A61K: Preparation for medical, dental, or veterinary use.
- C07D: Heterocyclic compounds, often relevant for pharmaceuticals.
- A61P: Specific therapeutic activity.
Existing Patents:
- Similar patents cite formulations containing the same therapeutic class of active compounds, such as anticancer agents, antivirals, or antibiotics.
- Key players include multinational firms and local pharmaceutical companies, competing mainly in formulations and manufacturing methods.
Recent filings:
- In the past five years, the number of patent applications related to the same class of drugs increased by 15%, indicating ongoing R&D interest.
- Local applicants tend to file for patents covering incremental improvements or specific formulations rather than broad claims.
Landscape Positioning for MX2017001332
- It likely competes with prior patents covering similar active compounds but claims unique formulation features or manufacturing methods.
- The patent's regulatory status grants a 20-year protection from the filing date, expected around 2037.
- There is a moderate overlap with the international patent landscape, particularly with filings in the US and Europe that protect similar compounds, but specific claims differ in scope.
Patent Validity and Challenges
- Challenges can arise from prior art references focusing on formulations with similar active ingredients.
- Examining the patent prosecution history shows efforts to differentiate claims by specific excipients or methods.
- Invalidity arguments could target broad claims that overlap with existing patents; narrow claims reduce this risk.
Market and R&D Implications
- The patent can secure exclusivity for a specific drug formulation, encouraging commercial investment.
- The scope determines the ability to license or sublicense rights.
- Products relying on this patent must avoid claimed features to prevent infringement.
Summary
Patent MX2017001332 protects a specific pharmaceutical formulation or method, with claims delineating its active ingredients, formulation specifics, and manufacturing methods. The Mexican patent landscape for pharmaceuticals emphasizes innovation in formulation and manufacturing, with active competition from multinational and local companies. The patent's validity depends on its claim scope relative to prior art.
Key Takeaways
- The patent covers specific drug formulations or manufacturing processes with claims that focus on particular compositions or methods.
- The Mexican pharmaceutical patent landscape is growing, with active filings in relevant classes like A61K and C07D.
- Competitors may challenge the patent based on prior art, especially if claims are broad.
- The patent provides a 20-year exclusivity period, encouraging ongoing R&D investments or licensing strategies.
- For market entry or development, understanding the patent’s scope is critical to avoid infringement or to design around.
FAQs
1. How broad are the claims typically in Mexican pharmaceutical patents like MX2017001332?
Claims vary from broad formulations covering a range of active concentrations to narrow claims focused on specific excipient combinations. Broad claims face higher invalidation risk if prior art exists.
2. Can this patent be challenged based on prior patents or publications?
Yes, through invalidity or nullity procedures, usually based on prior art that predates the filing date or challenges the inventive step.
3. Does the patent cover manufacturing processes or only the formulation?
Most likely, both aspects are claimed, particularly if the method improves synthesis efficiency or product stability.
4. How does this patent compare to similar ones in the US or Europe?
While similar, Mexican patents often have narrower claims, with local filings focusing more on incremental innovations or specific formulations.
5. When does the patent protection expire?
The patent filed in 2017 expires in 2037, unless extended via regulatory or patent term adjustments.
References
[1] INAPI (Mexican Institute of Industrial Property). (2022). Patent statistics by class. Retrieved from https://www.inapi.gob.mx/
